Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
The U.S. Food and Drug Administration is taking steps to exempt select direct-to-consumer genetic testing manufacturers from premarket review, agency commissioner Scott Gottlieb, MD, wrote in a Nov. 6 statement.
Surescripts, a health information network focused on e-prescriptions, joined forces with five EHR vendors and two pharmacy benefit managers to improve prescription price transparency, the company announced Nov. 7.
More than 2,300 employees at Eli Lilly's U.S. operations accepted voluntary buyouts, according to the Indianapolis Business Journal.
The Food and Drug Administration granted expanded approvals for two of Roche's cancer drugs this week.
A new defense policy bill would grant the U.S. Department of Defense power to approve drugs and medical devices for use in the military, reports Politico.
Amgen, a biopharmaceutical company headquartered in Thousand Oaks, Calif., will lay off 200 research and development workers by the end of the year, according to STAT.
Genentech, a biologics drugmaker owned by Roche, will slash 130 jobs or about 13 percent of its workforce at its Vacaville, Calif. plant as the company faces increased biosimilar competition, according to STAT.
Valeant Pharmaceuticals International on Monday shared plans to sell the female libido business it purchased in 2015 back to its original owners for a fraction of the price, reports Bloomberg.
The Food and Drug Administration on Nov. 2 approved Valeant Pharmaceuticals International's eye drug Vyzulta.
CVS Health will offer next-day delivery for prescription drugs and other retail products at its 9,700 stores nationwide next year, according to USA Today.